| Name | Walmart Pharmacy 10-0049 |
|---|---|
| Organization Name | Wal-mart Stores East Lp |
| Location | 1911 E Jackson St, Hugo, Oklahoma 74743 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (580) 326-7541 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics, announced today that it expanded its patent portfolio with additional patents covering worldwide rights to develop and commercialize NeuVax.
A new study published today in the Journal of the National Cancer Institute indicates that different therapies for early-stage breast cancer have very different relative values.
Tumor cells divide fast. They thus require a high supply of components for their DNA, like purines. The biosynthesis of purines could now be a new point of attack for chemotherapy. However, without a natural model, the search for an inhibitor for a cellular process is like the proverbial search for a needle in a haystack. An American research team has developed a clever way to quickly conjure the desired "needle" out of the hay, presenting several candidates to act as starting points for the design of a purine synthesis inhibitor.
A new, first-in-class treatment which is believed to use a double-action approach to fight MS by rebalancing the immune system, has today been authorised in the UK for people living with relapsing forms (the most common type) of the disease.
› Verified 6 days ago
| NPI Number | 1598783268 |
| Organization Name | WAL-MART STORES EAST LP |
| Doing Business As | WALMART PHARMACY 10-0049 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1911 E Jackson St, Hugo, OK 74743 |
| Phone Number | 580-326-7541 |
News Archive
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics, announced today that it expanded its patent portfolio with additional patents covering worldwide rights to develop and commercialize NeuVax.
A new study published today in the Journal of the National Cancer Institute indicates that different therapies for early-stage breast cancer have very different relative values.
Tumor cells divide fast. They thus require a high supply of components for their DNA, like purines. The biosynthesis of purines could now be a new point of attack for chemotherapy. However, without a natural model, the search for an inhibitor for a cellular process is like the proverbial search for a needle in a haystack. An American research team has developed a clever way to quickly conjure the desired "needle" out of the hay, presenting several candidates to act as starting points for the design of a purine synthesis inhibitor.
A new, first-in-class treatment which is believed to use a double-action approach to fight MS by rebalancing the immune system, has today been authorised in the UK for people living with relapsing forms (the most common type) of the disease.
› Verified 6 days ago
News Archive
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics, announced today that it expanded its patent portfolio with additional patents covering worldwide rights to develop and commercialize NeuVax.
A new study published today in the Journal of the National Cancer Institute indicates that different therapies for early-stage breast cancer have very different relative values.
Tumor cells divide fast. They thus require a high supply of components for their DNA, like purines. The biosynthesis of purines could now be a new point of attack for chemotherapy. However, without a natural model, the search for an inhibitor for a cellular process is like the proverbial search for a needle in a haystack. An American research team has developed a clever way to quickly conjure the desired "needle" out of the hay, presenting several candidates to act as starting points for the design of a purine synthesis inhibitor.
A new, first-in-class treatment which is believed to use a double-action approach to fight MS by rebalancing the immune system, has today been authorised in the UK for people living with relapsing forms (the most common type) of the disease.
› Verified 6 days ago
Complete Care Medical Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 422 E Jackson St, Hugo, Oklahoma 74743 Phone: (580) 326-4887 | |
Hugo Express Pharmacy Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1200 E Jackson Street, Hugo, Oklahoma 74743 Phone: (580) 326-1600 | |
Vision Source Of Hugo, Inc. Type: Durable Medical Equipment & Medical Supplies Supplier Location: 806 E Jackson St, Hugo, Oklahoma 74743 Phone: (580) 326-3319 | |
Walmart Pharmacy 10-0049 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1911 E Jackson St, Hugo, Oklahoma 74743 Phone: (580) 326-7541 |